Cargando…
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Although several angiogenesis-related factors are reportedly involved in the pathogenesis of ulcerative colitis (UC), the mechanisms by which they contribute to disease are unclear. We first examined the expression of angiogenesis-related factors in inflamed colorectal tissue of UC patients using an...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938860/ https://www.ncbi.nlm.nih.gov/pubmed/36806262 http://dx.doi.org/10.1038/s41598-023-29824-1 |
_version_ | 1784890723417456640 |
---|---|
author | Kida, Yoshifumi Okahisa, Toshiya Sato, Yasushi Bando, Masahiro Fujimoto, Shota Ma, Beibei Nakagawa, Tadahiko Kawaguchi, Tomoyuki Nakamura, Fumika Okamoto, Koichi Miyamoto, Hiroshi Sogabe, Masahiro Tsuneyama, Koichi Takayama, Tetsuji |
author_facet | Kida, Yoshifumi Okahisa, Toshiya Sato, Yasushi Bando, Masahiro Fujimoto, Shota Ma, Beibei Nakagawa, Tadahiko Kawaguchi, Tomoyuki Nakamura, Fumika Okamoto, Koichi Miyamoto, Hiroshi Sogabe, Masahiro Tsuneyama, Koichi Takayama, Tetsuji |
author_sort | Kida, Yoshifumi |
collection | PubMed |
description | Although several angiogenesis-related factors are reportedly involved in the pathogenesis of ulcerative colitis (UC), the mechanisms by which they contribute to disease are unclear. We first examined the expression of angiogenesis-related factors in inflamed colorectal tissue of UC patients using antibody array, and identified the 5 factors with highest expression, which included matrix metalloproteinase-8, urokinase-type plasminogen activator (uPA), angiostatin/plasminogen, hepatocyte growth factor and endoglin. Subsequent real-time PCR experiments using additional colorectal tissues revealed that uPA mRNA levels were significantly higher in inflamed tissues than in non-inflamed tissues, and significantly correlated with the severity of UC. Mirror section immunohistochemistry revealed that uPA was expressed in the neutrophils of inflamed colorectal tissues. We administered dextran sulfate sodium (DSS) in drinking water to uPA knockout (uPA(−/−)) mice, and found that the disease activity index in uPA(-/-) mice was marginally lower and the histological score in uPA(−/−) mice was significantly lower than those in wild-type mice, suggesting the importance of uPA in colitis. When an uPA-selective inhibitor, UK122, was administered to DSS-treated C57BL6J mice, the disease activity index and histological score in those mice were significantly lower compared with control mice. Multiple cytokine/chemokine assay using colorectal tissues from uPA(−/−) and UK122-treated mice revealed significantly lowered level of RANTES. In conclusion, uPA was highly expressed in neutrophils of the inflamed mucosa of UC patients, and the expression level correlated with the severity of UC. Genetic uPA deletion or pharmacological uPA blockade significantly ameliorated colitis in mice, concomitant with downregulation of RANTES. |
format | Online Article Text |
id | pubmed-9938860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99388602023-02-20 Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice Kida, Yoshifumi Okahisa, Toshiya Sato, Yasushi Bando, Masahiro Fujimoto, Shota Ma, Beibei Nakagawa, Tadahiko Kawaguchi, Tomoyuki Nakamura, Fumika Okamoto, Koichi Miyamoto, Hiroshi Sogabe, Masahiro Tsuneyama, Koichi Takayama, Tetsuji Sci Rep Article Although several angiogenesis-related factors are reportedly involved in the pathogenesis of ulcerative colitis (UC), the mechanisms by which they contribute to disease are unclear. We first examined the expression of angiogenesis-related factors in inflamed colorectal tissue of UC patients using antibody array, and identified the 5 factors with highest expression, which included matrix metalloproteinase-8, urokinase-type plasminogen activator (uPA), angiostatin/plasminogen, hepatocyte growth factor and endoglin. Subsequent real-time PCR experiments using additional colorectal tissues revealed that uPA mRNA levels were significantly higher in inflamed tissues than in non-inflamed tissues, and significantly correlated with the severity of UC. Mirror section immunohistochemistry revealed that uPA was expressed in the neutrophils of inflamed colorectal tissues. We administered dextran sulfate sodium (DSS) in drinking water to uPA knockout (uPA(−/−)) mice, and found that the disease activity index in uPA(-/-) mice was marginally lower and the histological score in uPA(−/−) mice was significantly lower than those in wild-type mice, suggesting the importance of uPA in colitis. When an uPA-selective inhibitor, UK122, was administered to DSS-treated C57BL6J mice, the disease activity index and histological score in those mice were significantly lower compared with control mice. Multiple cytokine/chemokine assay using colorectal tissues from uPA(−/−) and UK122-treated mice revealed significantly lowered level of RANTES. In conclusion, uPA was highly expressed in neutrophils of the inflamed mucosa of UC patients, and the expression level correlated with the severity of UC. Genetic uPA deletion or pharmacological uPA blockade significantly ameliorated colitis in mice, concomitant with downregulation of RANTES. Nature Publishing Group UK 2023-02-18 /pmc/articles/PMC9938860/ /pubmed/36806262 http://dx.doi.org/10.1038/s41598-023-29824-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Kida, Yoshifumi Okahisa, Toshiya Sato, Yasushi Bando, Masahiro Fujimoto, Shota Ma, Beibei Nakagawa, Tadahiko Kawaguchi, Tomoyuki Nakamura, Fumika Okamoto, Koichi Miyamoto, Hiroshi Sogabe, Masahiro Tsuneyama, Koichi Takayama, Tetsuji Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice |
title | Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice |
title_full | Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice |
title_fullStr | Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice |
title_full_unstemmed | Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice |
title_short | Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice |
title_sort | urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938860/ https://www.ncbi.nlm.nih.gov/pubmed/36806262 http://dx.doi.org/10.1038/s41598-023-29824-1 |
work_keys_str_mv | AT kidayoshifumi urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT okahisatoshiya urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT satoyasushi urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT bandomasahiro urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT fujimotoshota urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT mabeibei urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT nakagawatadahiko urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT kawaguchitomoyuki urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT nakamurafumika urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT okamotokoichi urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT miyamotohiroshi urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT sogabemasahiro urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT tsuneyamakoichi urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice AT takayamatetsuji urokinasetypeplasminogenactivatorblockadeamelioratesexperimentalcolitisinmice |